Novaseq 6000 high throughput next-generation sequencing (NGS) system
Ended Purchase Order Awarded Last action
- Contract number
- 75F40119P10173
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,480,189
Award facts
- Opportunity
-
- High Throughput Next-Generation Sequencing (NGS) System Solicitation · FDA192331210758 · Posted Mar 8, 2019
- Contract value 100% obligated
- $1,480,189.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $135,323 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$4,305 | |
| Exercise an Option | $130,119 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$4,789 | |
| Exercise an Option | $125,114 | |
| Exercise an Option | $120,302 | |
| Other Administrative Action | $0 | |
| Original award | $978,425 |
Show all 11
About this award
This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NovaSeq 6000 high throughput next-generation sequencing (NGS) system, with a potential value of $1,480,189.00. The system will be used to support the FDA's Center for Biologics Evaluation and Research (CBER) Facility for Biotechnology Resources, which provides NGS and other analytical services for research and review tasks related to pathogens, vaccines, blood products, and gene/cell therapies. The contract award does not include any set-aside designations, and is open to full and open competition.
Quick answers
Who was awarded contract 75F40119P10173?
75F40119P10173 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 21, 2019.
How much is contract 75F40119P10173 worth?
The government has obligated $1,480,189 on 75F40119P10173.
Was contract 75F40119P10173 competed?
The extent of competition for 75F40119P10173 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award